Sumatriptan and Taltz drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Sumatriptan (sumatriptan succinate) and Taltz (ixekizumab). Common drug interactions include headache among females and arteriosclerosis coronary artery among males.

The phase IV clinical study analyzes what interactions people have when they take Sumatriptan and Taltz. It is created by eHealthMe based on reports of 21 people who take the same drugs from the FDA, and is updated regularly.

What is Sumatriptan?

Sumatriptan has active ingredients of sumatriptan succinate. It is often used in migraine. eHealthMe is studying from 18,159 Sumatriptan users. Check the latest studies of Sumatriptan.

What is Taltz?

Taltz has active ingredients of ixekizumab. eHealthMe is studying from 29,778 Taltz users. Check the latest studies of Taltz.

On Aug, 09, 2026

21 people who take Sumatriptan and Taltz together, and have interactions are studied.

Sumatriptan and Taltz drug interactions.

What are the common drug interactions of Sumatriptan and Taltz, by gender? *:

female:

Headache (pain in head)
Fatigue (feeling of tiredness)
Pyrexia (fever)
Cystitis noninfective (non-infectious inflammation of the wall of the bladder)
Chills (felling of cold)
Constipation
Initial insomnia (feeling of inadequate or poor-quality sleep)
Listless (lack of interest, energy, or spirit)
Pain in jaw
Psoriatic arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop)

male:

Arteriosclerosis coronary artery (thickening and hardening of arteries- coronary artery)
Arthralgia (joint pain)
Upper gastrointestinal haemorrhage (upper gastrointestinal bleeding)
Varices oesophageal (enlarged and swollen veins at the bottom of the oesophagus, near the stomach)
Cardiomegaly (increased size of heart than normal)
Diarrhoea
Hyperbilirubinaemia (excess of bilirubin in the blood)
Intestinal polyp (small growths in the bowel with the potential for further growth)
Iron deficiency anaemia
Metabolic acidosis (body produces too much acid, or when the kidneys are not removing enough acid from the body)

What are the common drug interactions of Sumatriptan and Taltz, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

Headache (pain in head)
Fatigue (feeling of tiredness)
Pyrexia (fever)
Cystitis noninfective (non-infectious inflammation of the wall of the bladder)
Chills (felling of cold)
Constipation
Initial insomnia (feeling of inadequate or poor-quality sleep)
Listless (lack of interest, energy, or spirit)
Pain in jaw
Rhinorrhoea (watery mucus discharge from the nose)

30-39:

n/a

40-49:

Arterial occlusive disease (slow process through which arteries throughout the body become progressively narrowed and eventually completely blocked)
Arthralgia (joint pain)
Asthenia (weakness)
Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
Poor peripheral circulation
Sacral pain (pain at sacrum bone region)
Thrombosis (formation of a blood clot inside a blood vessel)
Weight decreased
Psoriatic arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop)

50-59:

Arteriosclerosis coronary artery (thickening and hardening of arteries- coronary artery)
Arthralgia (joint pain)
Metabolic acidosis (body produces too much acid, or when the kidneys are not removing enough acid from the body)
Motion sickness (travel sickness)
Portal hypertensive gastropathy (changes in the mucosa of the stomach in patients with portal hypertension;)
Splenomegaly (enlargement of spleen)
Upper gastrointestinal haemorrhage (upper gastrointestinal bleeding)
Varices oesophageal (enlarged and swollen veins at the bottom of the oesophagus, near the stomach)
Walking disability
Cardiomegaly (increased size of heart than normal)

60+:

n/a

What are the existing conditions these people have? *

Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 9 people, 42.86%
Fever: 5 people, 23.81%
Psoriasis (immune-mediated disease that affects the skin): 4 people, 19.05%
Immunodeficiency Common Variable: 4 people, 19.05%
Primary Immunodeficiency Syndrome: 2 people, 9.52%
Asthma: 2 people, 9.52%

* Approximation only. Some reports may have incomplete information.

Do you take Sumatriptan and Taltz?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously